SlideShare a Scribd company logo
1 of 10
Intersticijalna
pneumonija dojenčadi
uzrokovana
okulogenitalnom
klamidijom
Domina Petrić
Chlamydia
trachomatis
Uvod
• U novorođenčadi majki s kroničnom
genitalnom infekcijom
okulogenitalnom klamidijom može se
između 2. i 19. tjedna života razviti
intersticijalna pneumonija.
Obilježja pneumonije
• Opći simptomi bolesti (povišena
temperatura, malaksalost) su odsutni.
• Postoje učestali napadi tvrdokornog
grčevitog kašlja s povraćanjem i
gubitkom daha, slično hripavcu, ali
bez karakterističnog inspiratornog
hripanja.
Obilježja pneumonije
• Postoji tahipneja i preko 60/min te
blaga restriktivna dispneja kao odraz
intersticijske pneumonije.
• Auskultatorno se čuje normalan, ali
ubrzan i površan šum disanja bez
produljenog ekspirija, bez bronhalnog
zviždanja, ali često uz nalaz
obostranih krepitacija.
Obilježja pneumonije
• Rtg-ski se vidi umjereno pojačana
zračnost pluća uz difuzno, obostrano
pojačan hilifugalni intersticijalni crtež.
• Bolest ima dugotrajan (nekoliko
tjedana), ali dobroćudan tijek.
• Oko 50% djece ima uz pneumoniju i
konjunktivitis.
Obilježja pneumonije
• U pravilu razina IgG i IgM u serumu
te djece je povišena, a neka djeca
imaju blagu eozinofiliju u perifernoj
krvi.
• Etiologija se može dokazati u djece
koja imaju popratni konjunktivitis
(počne oko 10. dana života).
Dokazivanje uzročnika
• Uzima se bris konjunktive.
• Vide se intracitoplazmatske
inkluzije u deskvamiranim
epitelnim stanicama.
Citoplazmatska
inkluzijska
tjelešca
Ostale mikrobiološke
metode:
• dokazivanje klamidijske DNA
• dokazivanje specifičnih
klamidijskih IgM-protutijela
• kultura stanica
AB terapija
• Azitromicin
• Ofloksacin
• Levofloksacin
Literatura:
Duško Mardešić i
suradnici.
Pedijatrija
Školska knjiga,
Zagreb, 2003.

More Related Content

More from Domina Petric

Cardiorenal syndrome
Cardiorenal syndromeCardiorenal syndrome
Cardiorenal syndromeDomina Petric
 
Categorization of risks and benefits (food additives)
Categorization of risks and benefits (food additives)Categorization of risks and benefits (food additives)
Categorization of risks and benefits (food additives)Domina Petric
 
Benefits and risks of additives
Benefits and risks of additivesBenefits and risks of additives
Benefits and risks of additivesDomina Petric
 
Types of food additives
Types of food additivesTypes of food additives
Types of food additivesDomina Petric
 
Effector phase in immune mediated drug hypersensitivity
Effector phase in immune mediated drug hypersensitivityEffector phase in immune mediated drug hypersensitivity
Effector phase in immune mediated drug hypersensitivityDomina Petric
 
T cell stimulation by drugs
T cell stimulation by drugsT cell stimulation by drugs
T cell stimulation by drugsDomina Petric
 
Introduction to drug hypersensitivity reactions
Introduction to drug hypersensitivity reactionsIntroduction to drug hypersensitivity reactions
Introduction to drug hypersensitivity reactionsDomina Petric
 
Drug induced liver injury part II
Drug induced liver injury part IIDrug induced liver injury part II
Drug induced liver injury part IIDomina Petric
 
Drug induced liver injury part I
Drug induced liver injury part IDrug induced liver injury part I
Drug induced liver injury part IDomina Petric
 

More from Domina Petric (20)

ECG L
ECG LECG L
ECG L
 
ECG I
ECG IECG I
ECG I
 
ECG H
ECG HECG H
ECG H
 
ECG F
ECG FECG F
ECG F
 
ECG E
ECG EECG E
ECG E
 
ECG D
ECG DECG D
ECG D
 
ECG C
ECG CECG C
ECG C
 
ECG B
ECG BECG B
ECG B
 
ECG A: AVNRT, AVRT
ECG A: AVNRT, AVRTECG A: AVNRT, AVRT
ECG A: AVNRT, AVRT
 
ECG A: AV blocks
ECG A: AV blocksECG A: AV blocks
ECG A: AV blocks
 
ECG A: first part.
ECG A: first part.ECG A: first part.
ECG A: first part.
 
Cardiorenal syndrome
Cardiorenal syndromeCardiorenal syndrome
Cardiorenal syndrome
 
Categorization of risks and benefits (food additives)
Categorization of risks and benefits (food additives)Categorization of risks and benefits (food additives)
Categorization of risks and benefits (food additives)
 
Benefits and risks of additives
Benefits and risks of additivesBenefits and risks of additives
Benefits and risks of additives
 
Types of food additives
Types of food additivesTypes of food additives
Types of food additives
 
Effector phase in immune mediated drug hypersensitivity
Effector phase in immune mediated drug hypersensitivityEffector phase in immune mediated drug hypersensitivity
Effector phase in immune mediated drug hypersensitivity
 
T cell stimulation by drugs
T cell stimulation by drugsT cell stimulation by drugs
T cell stimulation by drugs
 
Introduction to drug hypersensitivity reactions
Introduction to drug hypersensitivity reactionsIntroduction to drug hypersensitivity reactions
Introduction to drug hypersensitivity reactions
 
Drug induced liver injury part II
Drug induced liver injury part IIDrug induced liver injury part II
Drug induced liver injury part II
 
Drug induced liver injury part I
Drug induced liver injury part IDrug induced liver injury part I
Drug induced liver injury part I
 

Intersticijalna pneumonija dojenčadi uzrokovana okulogenitalnom klamidijom